Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia often occurs after menopause, with delayed diagnosis and possible links to certain medications and conditions.

ITK inhibitors may effectively treat alopecia areata.

Fzd2 is important for skin and hair development through various signaling ways.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

Finasteride may help treat frontal fibrosing alopecia, but more research is needed.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Frontal fibrosing alopecia can occur in children, not just postmenopausal women.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Familial frontal fibrosing alopecia is rare, mostly affects women, and often occurs between sisters or mother-daughter pairs.

BTNL2 helps protect hair follicles from immune attacks.

Methotrexate may help stabilize frontal fibrosing alopecia.

A 66-year-old woman experienced hair loss due to Frontal Fibrosing Alopecia, a condition with no consistently effective treatment, but it usually stabilizes over time. More research is needed for better understanding and treatment options.

Using facial sunscreen and moisturizer may increase the risk of frontal fibrosing alopecia.

The TIP1 gene is crucial for normal plant cell growth in Arabidopsis.

Cosmetic treatments can replenish key amino acids in damaged hair, improving its strength and appearance.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

FFA in men shows unique features and treatment results vary widely.

The FAT1 gene and its variations can help improve wool quality in Chinese Merino sheep through selective breeding.

FP-1 is a key protein in rat hair growth, active only during the growth phase.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting postmenopausal women, with unclear causes.

Frontal fibrosing alopecia can occur in men and may be linked to immune triggers like vaccines.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.